Abstract: The present invention relates to application of gossypol and its optical isomers to preparation of an anti-Coronavirus drug. Specifically disclosed is application of pharmaceutically acceptable salts, solvates, isotopes, stereoisomers, stereoisomer mixtures, and tautomers of the gossypol and its optical isomers to preparation of a drug for preventing and/or treating a disease caused by a Coronavirus. The Coronavirus is MERS-CoV, SARS-CoV, or SARS-CoV-2. It is found in the present invention for the first time that the gossypol and its optical isomers can inhibit the activity of Coronavirus 3CL proteases to achieve an anti-Coronavirus effect. The half maximal inhibitory concentrations of gossypol and (?)-gossypol to SARS-CoV proteases and SARS-CoV-2 3CL proteases are all lower than 10 ?M. The anti-Coronavirus 3CL protease effect is good. Therefore, the gossypol and its optical isomers have the potential for use in the preparation of a drug for preventing and/or treating novel Coronavirus infections.

Abstract: The embodiment of the present disclosure provides a method for preparing a boron dipyrromethene (BODIPY) derivative and an application of the BODIPY derivative. The method comprises: 1) taking BODIPY-1, diphenylacetylene, copper acetate monohydrate, anhydrous sodium carbonate, and metal catalyst, and dispersing the BODIPY-1, the diphenylacetylene, the copper acetate monohydrate, the anhydrous sodium carbonate, and the metal catalyst in an organic solvent for carrying out a cyclization reaction to obtain a cyclization product mixture; 2) rotary evaporating the cyclization product mixture to obtain a concentrated solution of a reaction system; 3) purifying the concentrated solution of the reaction system by a column chromatography, continuing to rotary evaporate a purified product, and then drying a product after the rotary evaporating to obtain a photocatalytic material BODIPY-2.

Abstract: A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. The Linker is or and n is 1-6.

Abstract: A method of applying a hierarchical porous ZrO2 includes: dissolving a triblock copolymer in an organic solvent to obtain a solution A, dissolving a tannin extract in distilled water to obtain a solution B, mixing the solution A and the solution B and stirring to obtain a mixed solution; adding a zirconium salt to the mixed solution and stirring; heating the mixed solution in an oven to obtain ZrO2, promoting the conversion of the crystal form of ZrO2; calcining ZrO2 at a high temperature to obtain the hierarchical porous ZrO2; mixing the hierarchical porous ZrO2 with a solution containing a lysozyme protein; and absorbing the lysozyme protein to the hierarchical porous ZrO2.

Abstract: A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. In formula I and II, n is 1-6.

Abstract: A method of applying a hierarchical porous ZrO2 includes: dissolving a triblock copolymer in an organic solvent to obtain a solution A, dissolving a tannin extract in distilled water to obtain a solution B, mixing the solution A and the solution B and stirring to obtain a mixed solution; adding a zirconium salt to the mixed solution and stirring; heating the mixed solution in an oven to obtain ZrO2, promoting the conversion of the crystal form of ZrO2; calcining ZrO2 at a high temperature to obtain the hierarchical porous ZrO2; mixing the hierarchical porous ZrO2 with a solution containing a lysozyme protein; and absorbing the lysozyme protein to the hierarchical porous ZrO2.

Abstract: A method for preparing a hierarchical porous ZrO2 includes the following steps: S1, dissolving a triblock copolymer in an organic solvent to obtain a solution A, dissolving a tannin extract in distilled water to obtain a solution B, mixing the solution A and the solution B and stirring to obtain a mixed solution; S2, adding a zirconium salt to the mixed solution obtained in step S1 and stirring; S3, heating the mixed solution obtained in step S2 in an oven to obtain ZrO2, promoting the conversion of the crystal form of ZrO2; S4, calcining ZrO2 at a high temperature to obtain the hierarchical porous ZrO2.

Abstract: A leather finishing agent that can enhance the mechanical properties and ultraviolet resistance of leather and a preparation method thereof are disclosed that relate to the field of leather additives. It was prepared by using polyphenol as raw material, hexamethylene tetramine as auxiliary agent, and a protonic acid as solvent, then heating and adding water for hydrolysis and dispersion. The method has the advantages of low production cost, simple process, high preparation efficiency, green production process and environmental protection. The leather finishing agent can be used in the finishing section after leather tanning. After finishing, the mechanical properties of the leather were significantly enhanced, and its UV resistance was also significantly improved.

Abstract: A method for preparing a collagen from a chromium-containing tanned leather waste is disclosed. The method includes acid dechromation, obtaining a collagen aggregate, and converting the collagen aggregate to the collagen. The method also includes a reaction in a supercritical carbon dioxide reactor.

Abstract: A method of preparing an aesculin sturgeon skin gelatin with antioxidant activity and Enterococcus faecalis detection ability includes: 1) mixing a sturgeon skin gelatin and distilled water in a ratio of 1:15-1:25 (w/v) at 50-70° C. and filtering to obtain a sturgeon skin gelatin solution; 2) adding aesculin and a glycerin solution to the sturgeon skin gelatin solution, stirring the resulted sturgeon skin gelatin solution at 30-50° C. for 30 minutes, and filtering; and 3) removing air bubbles from the sturgeon skin gelatin solution of step 2) under reduced pressure, placing the sturgeon skin gelatin solution on an acrylic glass, and drying the sturgeon skin gelatin solution at in a vented oven 25° C. and 45-55% relative humidity for 24 hours to obtain the aesculin sturgeon skin gelatin film.

Abstract: A method for preparing a hierarchical porous ZrO2 includes the following steps: S1, dissolving a triblock copolymer in an organic solvent to obtain a solution A, dissolving a tannin extract in distilled water to obtain a solution B, mixing the solution A and the solution B and stirring to obtain a mixed solution; S2, adding a zirconium salt to the mixed solution obtained in step S1 and stirring; S3, heating the mixed solution obtained in step S2 in an oven to obtain ZrO2, promoting the conversion of the crystal form of ZrO2; S4, calcining ZrO2 at a high temperature to obtain the hierarchical porous ZrO2.

Abstract: A method for preparing a high fluffiness down by multiple treatments with metal salts includes: degreasing a down sample with a degreasing agent; washing the down sample with water; oxidizing the down sample with an oxidizing agent; washing the down sample with water; conducting a first crosslinking treatment with basic zirconium sulfate; washing the down sample with water; conducting a second crosslinking treatment with basic aluminum sulfate; washing the down sample with water; and drying the down sample to obtain the high fluffiness down.

Abstract: A method for preparing a collagen from a chromium-containing tanned leather waste is disclosed. The method includes acid dechromation, obtaining a collagen aggregate, and converting the collagen aggregate to the collagen. The method also includes a reaction in a supercritical carbon dioxide reactor.

Abstract: A compound having the formula I: is disclosed. A method of preparing the compound of formula I is also disclosed.

Abstract: A method of preparing an aesculin sturgeon skin gelatin with antioxidant activity and Enterococcus faecalis detection ability includes: 1) mixing a sturgeon skin gelatin and distilled water in a ratio of 1:15-1:25 (w/v) at 50-70° C. and filtering to obtain a sturgeon skin gelatin solution; 2) adding aesculin and a glycerin solution to the sturgeon skin gelatin solution, stirring the resulted sturgeon skin gelatin solution at 30-50° C. for 30 minutes, and filtering; and 3) removing air bubbles from the sturgeon skin gelatin solution of step 2) under reduced pressure, placing the sturgeon skin gelatin solution on an acrylic glass, and drying the sturgeon skin gelatin solution at in a vented oven 25° C. and 45-55% relative humidity for 24 hours to obtain the aesculin sturgeon skin gelatin film.